Glofitamab Results in Cost Savings Versus Epcoritamab in Diffuse Large B-Cell Lymphoma (DLBCL): A Total Cost of Care AnalysisZahra Mahmoudjafari,Danilo Di Maio,Jia Li,Katherine L. Rosettie,Anthony MasaquelBlood(2023)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要